<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04723433</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-59593</org_study_id>
    <nct_id>NCT04723433</nct_id>
  </id_info>
  <brief_title>Recovery of Ventilation After Anesthesia for Laparoscopic Nephrectomy</brief_title>
  <official_title>Recovery of Ventilation After General Anesthesia for Robotic-assisted Laparoscopic Nephrectomy: The Effect of Conservative Versus Liberal Oxygen Supplementation - A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized, controlled feasibility investigation is to characterize&#xD;
      pharmacologically induced ventilatory depression after anesthesia and examine how is affected&#xD;
      by the amount of supplemental oxygen patients are receiving in the immediate postoperative&#xD;
      period.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is characterize pharmacologically induced ventilatory depression&#xD;
      after anesthesia and examine how is affected by the amount of supplemental oxygen patients&#xD;
      are receiving in the immediate postoperative period, since hyperoxemia (ie., higher than&#xD;
      necessary partial pressure of oxygen in the arterial blood) has been associated with&#xD;
      ventilatory depression via suppression of the hypoxic ventilatory drive.&#xD;
&#xD;
      In this feasibility randomized controlled trial, the investigators plan to estimate and&#xD;
      compare the cumulative segment of time during which the transcutaneous partial pressure of&#xD;
      carbon dioxide will exceed an upper limit of 45 mmHg (i.e., TcPCO2 &gt; 45 mmHg) for the&#xD;
      90-min-long post-anesthesia period, between the conventional (titrated to an oxygen&#xD;
      saturation &gt; 96%) and the conservative (titrated to O2 saturation 90 -94%) O2 supplementation&#xD;
      interventions.&#xD;
&#xD;
      Hypothesis: Conservative use of O2 (titrated to an SpO2: 90 - 94%), will be associated with&#xD;
      less hypoventilation (i.e., less time spent with an TcPCO2 &gt; 45 mmHg) during recovery from&#xD;
      general anesthesia, compared to liberal O2 supplementation (SpO2 &gt; 96%).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2021</start_date>
  <completion_date type="Actual">June 15, 2021</completion_date>
  <primary_completion_date type="Actual">June 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>In the post-anesthesia care unit (PACU), participants will be randomized to receive conservative (titrated to an SpO2 between 90 and 94%) versus liberal (titrated to SpO2 &gt; 96%) oxygen supplementation, via a non-rebreather mask.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Transcutaneous partial pressure of carbon dioxide (TcPCO2)</measure>
    <time_frame>Ninety -minute period immediately post-anesthesia.</time_frame>
    <description>The cumulative segment of time during which the transcutaneous partial pressure of carbon dioxide (TcPCO2: primary outcome) will exceed an upper limit of 45 mmHg (i.e., TcPCO2 &gt; 45 mmHg)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Ventilatory Depression</condition>
  <condition>Postoperative Respiratory Complication</condition>
  <arm_group>
    <arm_group_label>&quot;Conservative O2 Supplementation&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxygen administration will titrated to a oxyhemoglobin saturation (SpO2) between 90 and 94%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Liberal O2 Supplementation&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxygen administration will titrated to an SpO2 &gt; 96%.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen gas -Conservative</intervention_name>
    <description>Oxygen administration will titrated to a oxyhemoglobin saturation (SpO2) between 90% and 94%.</description>
    <arm_group_label>&quot;Conservative O2 Supplementation&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen gas -Liberal</intervention_name>
    <description>Oxygen administration will titrated to a oxyhemoglobin saturation (SpO2) higher than 96%.</description>
    <arm_group_label>&quot;Liberal O2 Supplementation&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical status I-III&#xD;
&#xD;
          -  Body mass index (BMI) less than 40 kg/m2&#xD;
&#xD;
          -  Scheduled to undergo robotic-assisted radical laparoscopic nephrectomy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a diagnosis of chronic obstructive pulmonary disorder (COPD), severe&#xD;
             neurological, cardiopulmonary, psychiatric, or untreated thyroid disorder&#xD;
&#xD;
          -  Chronic pain condition that is being treated with opioids&#xD;
&#xD;
          -  Patients with a hematocrit lower than 30% at the end of surgery, or those with an&#xD;
             excessive blood loss, requiring transfusion of blood products during their surgery,&#xD;
             will be also excluded from the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 21, 2021</study_first_submitted>
  <study_first_submitted_qc>January 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>September 11, 2021</last_update_submitted>
  <last_update_submitted_qc>September 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Anthony Doufas</investigator_full_name>
    <investigator_title>Professor, Department of Anesthesiology, Perioperative and Pain Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

